Schedule of Stock Options Outstanding (Details)	3 Months Ended
Schedule of Stock Options Outstanding (Details)	Mar. 31, 2025 $ / shares shares
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number Outstanding	53,393,102
Number Exercisable	20,881,145
Range One [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise price \| $ / shares	$ 0.1200
Number Outstanding	2,425,000
Weighted Average Remaining Contractual Life	7 months 6 days
Number Exercisable	2,425,000
Range Two [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise price \| $ / shares	$ 0.2862
Number Outstanding	814,681
Weighted Average Remaining Contractual Life	4 years 7 months 6 days
Number Exercisable	271,562
Range Three [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise price \| $ / shares	$ 0.2862
Number Outstanding	49,503,421
Weighted Average Remaining Contractual Life	9 years 8 months 12 days
Number Exercisable	17,534,583
Range Four [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise price \| $ / shares	$ 0.2900
Number Outstanding	100,000
Weighted Average Remaining Contractual Life	7 months 6 days
Number Exercisable	100,000
Range Five [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise price \| $ / shares	$ 0.7500
Number Outstanding	550,000
Weighted Average Remaining Contractual Life	8 months 12 days
Number Exercisable	550,000

PROVECTUS BIOPHARMACEUTICALS, INC. 10-Q